XML 22 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total Shareholders’ Equity
Noncontrolling Interest (“NCI”)
FGL [Member]
FGL [Member]
Additional Paid-in Capital
FGL [Member]
Accumulated Other Comprehensive Income
FGL [Member]
Total Shareholders’ Equity
FGL [Member]
Noncontrolling Interest (“NCI”)
Spectrum Brands [Member]
Spectrum Brands [Member]
Common Stock
Spectrum Brands [Member]
Additional Paid-in Capital
Spectrum Brands [Member]
Accumulated Deficit
Spectrum Brands [Member]
Accumulated Other Comprehensive Income
Spectrum Brands [Member]
Total Shareholders’ Equity
Spectrum Brands [Member]
Noncontrolling Interest (“NCI”)
Common stock, shares issued, beginning balance at Sep. 30, 2013   142,400,000                                  
Permanent equity, beginning balance at Sep. 30, 2013 $ 1,133.5 $ 1.4 $ 828.0 $ (192.4) $ 87.7 $ 724.7 $ 408.8                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net (loss) income 101.7     (10.3)   (10.3) 112.0                        
Unrealized investment gains, net 240.7       197.7 197.7 43.0                        
Other unrealized gains 11.5       6.8 6.8 4.7                        
Actuarial adjustments to pension plans (5.7)       (4.0) (4.0) (1.7)                        
Translation adjustment (32.5)       (19.1) (19.1) (13.4)                        
Comprehensive income (loss) $ 315.7         171.1 144.6                        
Repurchase of common stock, shares (5,197,000) (5,200,000)                                  
Repurchase of common stock, value $ (65.6) $ (0.1) (65.5)     (65.6)                          
Stock Issued During Period, Value, New Issues               $ 172.6 $ (58.5) $ (25.5) $ (84.0) $ 256.6              
Issuance (purchase) of subsidiary stock (8.3)   (11.1)     (11.1) 2.8                        
Exercise of stock options, shares   0                                  
Exercise of stock options, value 2.8   2.8   0.0 2.8                          
Stock compensation, shares   3,200,000                                  
Stock compensation 93.0 $ 0.1 72.3     72.4 20.6                        
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Redeemed During Period Shares   100,000                                  
Restricted stock surrendered for tax withholding (31.5)   (21.1)     (21.1) (10.4)                        
Preferred stock dividends, accretion and loss on conversion (73.6)     (73.6)   (73.6)                          
Conversion of preferred stock, shares   62,000,000                                  
Conversion of preferred stock, value 726.0 $ 0.6 725.4     726.0                          
NCI in acquired subsidiary 20.7   0.0     0.0 20.7                        
Dividend paid by subsidiary to NCI (28.3)           (28.3)                        
Common stock, shares issued, ending balance at Sep. 30, 2014   202,300,000                                  
Permanent equity, ending balance at Sep. 30, 2014 2,257.0 $ 2.0 1,472.3 (276.3) 243.6 1,441.6 815.4                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net (loss) income (512.4)     (556.8)   (556.8) 44.4                        
Unrealized investment gains, net (256.6)       (206.1) (206.1) (50.5)                        
Other unrealized gains (13.1)       (7.5) (7.5) (5.6)                        
Actuarial adjustments to pension plans (11.7)       (7.0) (7.0) (4.7)                        
Translation adjustment (112.9)       (65.7) (65.7) (47.2)                        
Comprehensive income (loss) $ (906.7)         (843.1) (63.6)                        
Repurchase of common stock, shares (6,900,000) (1,700,000)                                  
Repurchase of common stock, value $ (22.2) $ (0.1) (22.1)     (22.2)                          
Stock Issued During Period, Value, New Issues                         $ 281.0 $ 0.0 $ 29.9 $ 0.0 $ 1.3 $ 31.2 $ 249.8
Issuance (purchase) of subsidiary stock (61.0)   (76.8)   0.7 (76.1) 15.1                        
Exercise of stock options, shares   700,000                                  
Exercise of stock options, value 4.1 $ 0.0 4.1     4.1                          
Stock compensation, shares   1,400,000                                  
Stock compensation 90.0 $ 0.1 71.0     71.1 18.9                        
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Redeemed During Period Shares   (1,300,000)                                  
Restricted stock surrendered for tax withholding (21.0)   (19.9)     (19.9) (1.1)                        
NCI in acquired subsidiary 0.8   0.0     0.0 0.8                        
Dividend paid by subsidiary to NCI $ (33.9)           (33.9)                        
Common stock, shares issued, ending balance at Sep. 30, 2015 201,383,800 201,400,000                                  
Permanent equity, ending balance at Sep. 30, 2015 $ 1,588.1 $ 2.0 1,458.5 (833.1) (40.7) 586.7 1,001.4                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net (loss) income (33.9)     (198.8)   (198.8) 164.9                        
Unrealized investment gains, net 347.9       279.3 279.3 68.6                        
Other unrealized gains 7.1       4.1 4.1 3.0                        
Actuarial adjustments to pension plans (28.5)       (16.6) (16.6) (11.9)                        
Translation adjustment (8.5)       (4.8) (4.8) (3.7)                        
Comprehensive income (loss) $ 284.1         63.2 220.9                        
Repurchase of common stock, shares (6,900,000)                                    
Issuance (purchase) of subsidiary stock $ (54.5) $ 0.0 (34.6)   (0.4) (35.0) (19.5)                        
Exercise of stock options, shares   600,000                                  
Exercise of stock options, value 4.4 $ 0.0 4.4     4.4                          
Stock compensation, shares   0                                  
Stock compensation 64.3 $ 0.0 42.9     42.9 21.4                        
Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Redeemed During Period Shares   (1,200,000)                                  
Restricted stock surrendered for tax withholding (28.7) $ 0.0 (24.1)     (24.1) (4.6)                        
NCI in acquired subsidiary 0.0 $ 0.0 0.0     0.0 0.0                        
Dividend paid by subsidiary to NCI $ (40.5)           (40.5)                        
Common stock, shares issued, ending balance at Sep. 30, 2016 200,789,100.00 200,800,000                                  
Permanent equity, ending balance at Sep. 30, 2016 $ 1,817.2 $ 2.0 $ 1,447.1 $ (1,031.9) $ 220.9 $ 638.1 $ 1,179.1